The global medical robotic systems market size reached US$ 16.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 50.9 Billion by 2028, exhibiting a growth rate (CAGR) of 19.3% during 2023-2028.
Medical robotic systems include robots that are utilized in the healthcare industry for surgical interventions and rehabilitation. Typically, these systems consist of mechanical arms with attached surgical instruments, and an installed camera. The most commonly used robotic systems include computer-controlled electromechanical devices called telemanipulators, which use the actions of the surgeon on one side to control the effector on the other side. These systems provide advanced visualization functionalities using HD cameras that provide surgeons with a detailed view of the concerned area, illustrated up to microscopic structures. Besides this, the robotic systems also offer relatively improved technical dexterity as they can rotate 360 degrees with superior maneuverability. Since they enable surgeons to reach hard-to-access areas in an efficient manner, they are extensively used as a crucial component in remotely controlled, minimally invasive procedures.
Medical Robotic Systems Market Trends:
The market is majorly driven by the increasing demand for minimally invasive surgeries (MIS). This can be attributed to the escalating preference for smaller incisions, fewer cuts, decreased scarring, reduced pain, improved safety, and faster recovery periods that are associated with MIS across the surgical domain. In line with this, the rising geriatric population and the continual technological advancements in novel surgical modalities are propelling the market growth across the globe. The market is further driven by the growing funding for research and development (R&D) activities focusing on medical robotics and the expanding healthcare expenditure. Some of the other factors contributing to the product demand include continual technological advancements, the augmenting need for automation in the healthcare industry, a considerable rise in the cases of trauma injuries, and the rapidly expanding medical tourism sector.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical robotic systemsmarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, deployment mode and end user.
Breakup by Product:
Orthopedic Surgical Robots
Neurosurgical Robotic Systems
Laparoscopy Robotic Systems
Steerable Robotic Catheters
Exoskeleton Robotic Systems
Noninvasive Radiosurgery Robots
TrueBeam STx Radiosurgery System
CyberKnife Robotic Radiosurgery System
Gamma Knife Perfexion Radiosurgery System
Hospital and Pharmacy Robots
Cart Transportation Robots
Emergency Response Robotic Systems
Breakup by Deployment Mode:
Breakup by End User:
Ambulatory Surgical Centers
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Auris Health Inc. (Johnson & Johnson), DENSO Corporation, Intuitive Surgical Inc., iRobot Corporation, Medtronic plc, Omnicell Inc., Renishaw plc, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Titan Medical Inc. and Zimmer Biomet.
Base Year of the Analysis
Product, Deployment Mode, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Accuray Incorporated, Auris Health Inc. (Johnson & Johnson), DENSO Corporation, Intuitive Surgical Inc., iRobot Corporation, Medtronic plc, Omnicell Inc., Renishaw plc, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Titan Medical Inc. and Zimmer Biomet
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global medical robotic systems market was valued at US$ 16.1 Billion in 2022.
We expect the global medical robotic systems market to exhibit a CAGR of 19.3% during 2023-2028.
The rising need for automation in the healthcare industry, along with the growing adoption of robotic systems, such as computer-controlled electromechanical devices, that utilize the actions of the surgeon on one side to control the effector on the other side, is primarily driving the global medical robotic systems market.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective various surgical interventions to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for medical robotic systems.
Based on the product, the global medical robotic systems market can be bifurcated into surgical robots, rehabilitation robots, noninvasive radiosurgery robots, hospital and pharmacy robots, and emergency response robotic systems. Currently, surgical robots hold the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global medical robotic systems market include Accuray Incorporated, Auris Health Inc. (Johnson & Johnson), DENSO Corporation, Intuitive Surgical Inc., iRobot Corporation, Medtronic plc, Omnicell Inc., Renishaw plc, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Titan Medical Inc., and Zimmer Biomet.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.